Therapeuticsmd Inc (TXMD) Return on Assets ROA from the second quarter of 2026 to second quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Therapeuticsmd Inc   (NASDAQ: TXMD)


Therapeuticsmd Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Therapeuticsmd Inc 's ROA in the second quarter of 2026?
Therapeuticsmd Inc recorded a cumulative net loss of $0 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -0.57%.

However, within the Healthcare sector 216 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 2433, from total ROA ranking in the first quarter of 2026 at 3140.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Total Assets Change -2.53 % -1.71 % 6.53 % -81.1 % 14.66 %
Y / Y Net Income Change -71.87 % - - - -
Net Income (TTM) in million 0 0 -1 -1 -1
Return On Assets (TTM) -0.57 % 0.47 % -1.49 % -2.76 % -1.51 %
TXMD's Total Ranking # 2433 # 3140 # 2867 # 3017 # 3267
Total Assets (TTM) in million 38 38 38 39 39
Seq. Total Assets Change -0.14 % -0.2 % -2.62 % 0.43 % 0.7 %
Seq. Net Income Change 63.16 % - - -72.41 % -

TXMD's 5 Years Annual ROA >> Back to TXMD Management Effectiveness >> Compare TXMD ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 72
Sector # 217
Overall # 2595

Return On Assets Statistics
High Average Low
146.38 %
-59.62 %
-749.09 %
(Mar 31 2023)   (Dec 31 2012)





Financial Statements
Therapeuticsmd Inc 's Assets $ 38 million TXMD's Balance sheet
Therapeuticsmd Inc 's Income $ 0 million Quarterly TXMD's Income Statement
TXMD's Income by Division See TXMD's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025		 (Dec 31 2024)
FY 2024		 (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021
Y / Y Total Assets Change -81.6 % -7.95 % 163.46 % -47.91 % 17.73 %
Total Assets in million 38 205 222 84 162
Y / Y Net Income Change - - - - -
Net Income in million -1 -2 -10 112 -172
Annual Return On Assets -1.51 % -1.07 % -4.62 % 132.74 % -106.44 %

TXMD's 5 Years Annual ROA >> Back to TXMD Management Effectiveness >> Compare TXMD ROA to its Competitors



More Return On Assets Ratios
TXMD's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
TXMD's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for TXMD's Competitors
Subscribers only: Roa for Therapeuticsmd Inc 's Suppliers
Subscribers only: Return On Assets for TXMD's Customers

You may also want to know
TXMD's Roi TXMD's Inventory Turnover Ratio TXMD's Growth Rates TXMD's Dividend Comparisons
TXMD's Profitability Ratios TXMD's Asset Turnover Ratio TXMD's Dividend Growth
TXMD's Roe TXMD's Valuation Ratios TXMD's Financial Strength Ratios TXMD's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector ROA

Date modified: 2026-09-12T06:13:38+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.